Showing results (951-960 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|September 1, 1989
Biomimetic models for monooxygenasesS Zbaida, R KarivBiopharmaceutics & Drug Disposition|August 22, 2015
Physiologically based pharmacokinetics model predicts the lack of inhibition by repaglinide on the metabolism of pioglitazoneQingqing Xiao, Liling Tang, Ruijuan Xu, et al.Biopharmaceutics & Drug Disposition|July 30, 2015
Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoidsTomohide Uno, Chika Ogura, Chiho Izumi, et al.Biopharmaceutics & Drug Disposition|December 30, 2014
Dealing with the complex drug-drug interactions: towards mechanistic modelsManthena V Varma, K Sandy Pang, Nina Isoherranen, et al.Biopharmaceutics & Drug Disposition|July 1, 1989
Pharmacokinetics of lisinopril (IV/PO) in healthy volunteersB Beermann, A E Till, H J Gomez, et al.Biopharmaceutics & Drug Disposition|November 7, 2019
Adult and infant pharmacokinetic profiling of dihydrocodeine using physiologically based pharmacokinetic modelingMiki Ota, Makiko Shimizu, Yusuke Kamiya, et al.Biopharmaceutics & Drug Disposition|November 7, 2019
Pharmacokinetic profile analyses for inhaled drugs in humans using the lung delivery and disposition modelAnuja Raut, Sneha Dhapare, Jürgen Venitz, et al.Biopharmaceutics & Drug Disposition|February 5, 2020
Population pharmacokinetics of high-dose methotrexate in Chinese pediatric patients with medulloblastomaZheng-Yuan Shi, Ya-Ou Liu, Hong-Yan Gu, et al.Biopharmaceutics & Drug Disposition|January 12, 2020
Effects of osthol on activity, mRNA and protein expression of Cyp3a in rats in vivoWei Huang, Yu-Qing Xiong, Chun-Hua Xia, et al.Biopharmaceutics & Drug Disposition|November 1, 1988
The potential role of lysosomes in tissue distribution of weak basesA C MacIntyre, D J CutlerPageof 214